These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6764597)
1. [Anticoagulants and the eye]. Mathis A; Camuzet F Annee Ther Clin Ophtalmol; 1982; 33():299-315. PubMed ID: 6764597 [No Abstract] [Full Text] [Related]
2. The anticoagulant treatment of Eales' disease. Casanovas J; Castillo R Bibl Ophthalmol; 1968; 76():166-71. PubMed ID: 5674839 [No Abstract] [Full Text] [Related]
3. Use of conjugated estrogens in eye diseases. Busch S Ann Ophthalmol; 1976 May; 8(5):549-53. PubMed ID: 180865 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous vitreous hemorrhage. Butner RW; McPherson AR Ann Ophthalmol; 1982 Mar; 14(3):268-70. PubMed ID: 7092037 [TBL] [Abstract][Full Text] [Related]
5. A method to free retina and vitreous from intraoperative incarceration in the sclerotomy. Stopa M; Toth CA Retina; 2006; 26(9):1070-1. PubMed ID: 17151496 [No Abstract] [Full Text] [Related]
6. [Immobilized streptokinase (streptodecase) in the treatment of traumatic intra-ocular hemorrhage]. Gundorova RA; Romashchenko AD Vopr Med Khim; 1985; 31(4):47-51. PubMed ID: 4049786 [TBL] [Abstract][Full Text] [Related]
7. [Our experience in using collalysine]. Pavlenko OA Oftalmol Zh; 1986; (3):188. PubMed ID: 3014411 [No Abstract] [Full Text] [Related]
8. [Conjunctival, retinal, and vitreous hemorrhages during long term anticoagulant treatment]. Neumann L Bull Mem Soc Fr Ophtalmol; 1973; 86(0):164-6. PubMed ID: 4211367 [No Abstract] [Full Text] [Related]
9. Intravitreal urokinase in the management of vitreous haemorrhage. Sellors PJ; Kanski JJ; Watson DM Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):591-8. PubMed ID: 4534196 [No Abstract] [Full Text] [Related]
10. Vitreous opacity and blindness in young diabetics. Whittington TH Trans Ophthalmol Soc U K (1962); 1964; 84():469-83. PubMed ID: 5227434 [No Abstract] [Full Text] [Related]
11. [Clinical experiences with pyridinolcarbamate in ophthalmology]. Musini A; Fabbri G; Tancini G Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):101-23. PubMed ID: 5398786 [No Abstract] [Full Text] [Related]
13. New indications for and technics in vitreoretinal surgery. Vezendi L; Facskó A; Zajácz M; Berta A Acta Chir Hung; 1997; 36(1-4):381-2. PubMed ID: 9408410 [TBL] [Abstract][Full Text] [Related]
14. [On the new guidelines for inhibitors of hemostasis and regional neuraxial anesthesia]. Martín Rubio AM; Aguilar Franco C Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):199-200; author reply 200-1. PubMed ID: 16671267 [No Abstract] [Full Text] [Related]
15. [Treatment of the massive suprachoroidal hemorrhages]. Pastor JC; Baílez C; Aragón J; Rodríguez de la Rúa E Arch Soc Esp Oftalmol; 2001 Apr; 76(4):235-40. PubMed ID: 11340514 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of vitreous body opacity]. Tokuda H Ganka; 1969 Oct; 11(10):817-22. PubMed ID: 5392193 [No Abstract] [Full Text] [Related]
17. [Blindness in the infant following nontraumatic hemorrhage of the vitreous body]. Verin P; Comte P Bull Soc Ophtalmol Fr; 1985 Feb; 85(2):283-4, 287-8. PubMed ID: 4085119 [No Abstract] [Full Text] [Related]
18. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689 [TBL] [Abstract][Full Text] [Related]